We are monitoring the impact of COVID-19 on APAC Vaccine Contract Manufacturing Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 7580
Share on
Share on

Asia Pacific Vaccine Contract Manufacturing Market Research Report – Segmented By Service Type, Product Type, Vaccine Type and Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Size, Share, Trends and Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 7580
Pages: 145

Asia Pacific Vaccine Contract Manufacturing Market Size (2021 to 2026)

The size of the Vaccine contract manufacturing market in APAC was about USD 225.09 million in 2021. It is expected to rise at a CAGR of 9.8% and go up to USD 359.23 million by 2026. The main reason behind it is speculated to research advancements and increase in population. Also, there has been increasing in the trend of mergers and acquisitions in the region leading to wide spectrum organisations.

The vaccine is a biological element prepared to assist the immunity of a person against one or several diseases. Contracted Vaccine manufacturing establishment has higher qualitative and quantitative controlling standards with a significant margin of fixed costs, and production & development linked difficulties, have limited competition between vaccine manufacturers. Moreover, these complications have restricted the vaccine contract manufacturing size to a great extent.

Recent progress in biomanufacturing and biotechnology have led to the development of ground-breaking technologies that are capable of addressing the difficulties related to the manufacture of vaccines. Therefore, there is an increase in Vaccine contract manufacturing market growth. Earlier, the vaccine market was targeted towards preventive vaccines and mass production against infectious diseases. The beginning of therapeutic vaccines has changed interest in this field by paving method for vaccines to be developed for a diversity of chronic and degenerative ailments, which has promoted the entry of a number of manufacturers and blooming stakeholders who are competing for a market investment in this potential market segment.

This research report on the APAC vaccine contract manufacturing market has been segmented and sub-segmented into the following categories:

By Service Type:

  • Bulk Product
  • Fill Finish

By Product Type:

  • Single Vaccine
    • Influenza Virus
    • Ebola Virus
    • Chickenpox
    • Tetanus
    • Tuberculosis
    • Polio
    • Smallpox
    • Others
  • Combination Type

By Vaccine Type:

  • Inactivated Vaccines
  • Conjugate Vaccines
  • Live Attenuated Vaccines
  • Toxoid Vaccines
  • Recombinant Vector Vaccines
  • Subunit Vaccines
  • Synthetic Vaccines

By Country:

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Geographically, the Asia Pacific vaccine contract manufacturing market is majorly located in India, China, Indonesia, and Korea. The Asia Pacific is the largest “emerging” market for vaccine contract manufacturing with a huge market scope and big overhaul in research and development. Manufacturing in this region has spread its roots to a significant extent because of support from the local governments in terms of decreased taxation and other perks.

The leading manufacturers working in the Asia Pacific vaccine contract manufacturing market include Merck, Baxter International, Crucell, Sanofi Pasteur, Emergent BioSolutions, Novartis, Bavarian Nordic A/S, Pfizer Inc, Sinovac Biotech, Ltd and GlaxoSmithKline.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Service Type                              

                                5.1.1 Introduction           

                                5.1.2 Bulk Product           

                                5.1.3 Fill Finish  

                                5.1.4  Y-o-Y Growth Analysis, By Service Type     

                                5.1.5  Market Attractiveness Analysis, By Service Type   

                                5.1.6  Market Share Analysis, By Service Type    

                5.2 Product Type                             

                                5.2.1 Introduction           

                                5.2.2 Single Vaccine        

                                                5.2.2.1 Influenza Virus

                                                5.2.2.2 Chicken Pox

                                                5.2.2.3 Ebola Virus

                                                5.2.2.4 Tetanus

                                                5.2.2.5 Tuberculosis

                                                5.2.2.6 Polio

                                                5.2.2.7 Small Pox

                                5.2.3 Combination Vaccine          

                                5.2.4 Y-o-Y Growth Analysis, By Product Type    

                                5.2.5 Market Attractiveness Analysis, By Product Type  

                                5.2.6 Market Share Analysis, By Product Type    

                5.3 Vaccine Type                             

                                5.3.1 Introduction           

                                5.3.2 Inactivated Vaccines           

                                5.3.3 Conjugate Vaccines             

                                5.3.4 Live Attenuated    

                                5.3.5 Toxoid Vaccines    

                                5.3.6 Recombinant Vector Vaccines        

                                5.3.7 Subunit Vaccines  

                                5.3.8 Synthetic Vaccines               

                                5.3.9 Y-o-Y Growth Analysis, By Vaccine Type     

                                5.3.10  Market Attractiveness Analysis, By Vaccine Type               

                                5.3.11  Market Share Analysis, By Vaccine Type

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Service Type

                                                6.1.3.3 By Product Type

                                                6.1.3.4 By Vaccine Type

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Service Type

                                                6.1.4.3 By Product Type

                                                6.1.4.4 By Vaccine Type

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Service Type

                                                6.1.5.3 By Product Type

                                                6.1.5.4 By Vaccine Type

                6.2 China                             

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea                               

                6.6 Australia                      

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Bavarian Nordic A/S                

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Thomas Jefferson University                              

                8.3 Goodwin Biotechnology Inc.                               

                8.4 BioMARK                     

                8.5 Emergent BioSolutions                          

                8.6 Soligenix Inc.                              

                8.7 Catalent Biologics                     

                8.8 Minneapolis Medical Research Foundation                  

                8.9 FUJIFILM Diosynth Biotechnologies                 

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of service center, by Product type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

                                                                                                                          

  1. Asia Pacific Vaccine Contract Manufacturing Market, By Service Type, From 2021 to 2026 (USD Million)
  2. Asia Pacific Bulk Type Market, By Region, From 2021 to 2026 (USD Million)
  3. Asia Pacific Fill Finish Market, By Region, From 2021 to 2026 (USD Million)
  4. Asia Pacific Vaccine Contract Manufacturing Market, By Product Type, From 2021 to 2026 (USD Million)
  5. Asia Pacific Single Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  6. Asia Pacific Combination Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  7. Asia Pacific Vaccine Contract Manufacturing Market, By Vaccine Type, From 2021 to 2026 (USD Million)
  8. Asia Pacific Inactivated Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  9. Asia Pacific Conjugated Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  10. Asia Pacific Recombinant Vector Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  11. Asia Pacific Live Attenuated Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  12. Asia Pacific Toxoid Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  13. Asia Pacific Sub Unite Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  14. Asia Pacific Synthetic Vaccine Market, By Region, From 2021 to 2026 (USD Million)
  15. Japan Vaccine Contract Manufacturing Market, By Service Type, From 2021 to 2026 (USD Million)
  16. Japan Vaccine Contract Manufacturing Market, By Product Type, From 2021 to 2026 (USD Million)
  17. Japan Vaccine Contract Manufacturing Market, By Vaccine Type, From 2021 to 2026 (USD Million)
  18. China Vaccine Contract Manufacturing Market, By Service Type, From 2021 to 2026 (USD Million)
  19. China Vaccine Contract Manufacturing Market, By Product Type, From 2021 to 2026 (USD Million)
  20. China Vaccine Contract Manufacturing Market, By Vaccine Type, From 2021 to 2026 (USD Million)
  21. India Vaccine Contract Manufacturing Market, By Service Type, From 2021 to 2026 (USD Million)
  22. India Vaccine Contract Manufacturing Market, By Product Type, From 2021 to 2026 (USD Million)
  23. India Vaccine Contract Manufacturing Market, By Vaccine Type, From 2021 to 2026 (USD Million)
  24. Australia Vaccine Contract Manufacturing Market, By Service Type, From 2021 to 2026 (USD Million)
  25. Australia Vaccine Contract Manufacturing Market, By Product Type, From 2021 to 2026 (USD Million)
  26. Australia Vaccine Contract Manufacturing Market, By Vaccine Type, From 2021 to 2026 (USD Million)
  27. South Korea Vaccine Contract Manufacturing Market, By Service Type, From 2021 to 2026 (USD Million)
  28. South Korea Vaccine Contract Manufacturing Market, By Product Type, From 2021 to 2026 (USD Million)
  29. South Korea Vaccine Contract Manufacturing Market, By Vaccine Type, From 2021 to 2026 (USD Million)
  30. Asia Pacific Vaccine Contract Manufacturing Market, By Single Vaccine, From 2021 to 2026 (USD Million)
  31. Asia Pacific Influenza Virus Market, By Region, From 2021 to 2026 (USD Million)
  32. Asia Pacific Chicken Pox Market, By Region, From 2021 to 2026 (USD Million)
  33. Asia Pacific Ebola Virus Market, By Region, From 2021 to 2026 (USD Million)
  34. Asia Pacific Tetanus Market, By Region, From 2021 to 2026 (USD Million)
  35. Asia Pacific Tubercolosis Market, By Region, From 2021 to 2026 (USD Million)
  36. Asia Pacific Polio Market, By Region, From 2021 to 2026 (USD Million)
  37. Asia Pacific Small Pox Market, By Region, From 2021 to 2026 (USD Million)
  38. Japan Vaccine Contract Manufacturing Market, By Single Vaccine, From 2021 to 2026 (USD Million)
  39. China Vaccine Contract Manufacturing Market, By Single Vaccine, From 2021 to 2026 (USD Million)
  40. India Vaccine Contract Manufacturing Market, By Single Vaccine, From 2021 to 2026 (USD Million)
  41. Australia Vaccine Contract Manufacturing Market, By Single Vaccine, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample